6 Results for "

GS-cAMP

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "GS-cAMP" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-108742
CAS No.: 247062-33-5
Purity:  99.91%
Synonyms: BA 058; BIM 44058
Target:  

PTHR Arrestin

Research Areas:  

Metabolic Disease Cancer

Abaloparatide (BA 058) is a parathyroid hormone receptor 1 (PTHR1) analog. Abaloparatide also is a selective PTHR1 activator. Abaloparatide enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide enhances bone formation and cortical structure in mice. Abaloparatide has the potential for the research of osteoporosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108742A
Purity:  99.86%
Synonyms: BA 058 TFA; BIM 44058 TFA
Target:  

Arrestin PTHR

Research Areas:  

Metabolic Disease Endocrinology Cancer

Abaloparatide TFA (BA 058 TFA) is a parathyroid hormone receptor 1 (PTHR1) analogue. Abaloparatide TFA also is a selective PTHR1 activator. Abaloparatide TFA enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide TFA enhances bone formation and cortical structure in mice. Abaloparatide TFA has the potential for the research of osteoporosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141495
CAS No.: 1643462-93-4
Purity:  97.09%
Synonyms: PW0464
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

PW0464, a nanomolar potent complete G protein biased ligand, is a noncatechol D1R agonist, with an EC50 of 5.8 nM (Gs-cAMP) .
loading...
    loading...
Cat. No.: HY-P6292
CAS No.: 2724212-01-3
Research Areas:  

Neurological Disease Cancer

KS-133 is a bicyclic peptide with VIPR2 antagonistic activity that can cross the blood-brain barrier. KS-133 selectively blocks VIPR2-mediated Gq/Ca, Gs/cAMP, cAMP/PKA/ERK and PI3K/AKT/GSK3β signaling pathways. KS-133 inhibits VIPR2 agonist-induced CREB phosphorylation in the prefrontal cortex of mice. KS-133 shifts the polarization direction of macrophages toward M1. KS-133 attenuates cancer cell proliferation and reduces the cell cycle distribution level at the S-M phase. KS-133 exerts antitumor effects in a mouse model of colorectal cancer. KS-133 reverses cognitive decline in mouse models of psychiatric disorders. KS-133 can be used for research related to schizophrenia, colorectal cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-119486A
CAS No.: 1643462-64-9
Purity:  99.87%
Synonyms: (Rac)-PF-06649751; (Rac)-CVL-751
Research Areas:  

Neurological Disease

(Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity .
loading...
    loading...
Cat. No.: HY-145156
CAS No.: 2212020-93-2
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

CHU-128 is an effective and selective GLP-1R agonist. CHU-128 exhibits strong signal specificity and can activate the Gs/cAMP pathway, but it cannot activate the Gq/calcium signal, ERK phosphorylation, or recruit β-inhibitory proteins. CHU-128 can be used for research on type 2 diabetes .
loading...
    loading...